|
|
血小板对肝癌发生、发展及治疗影响的研究进展
|
Abstract:
本文全面回顾了血小板在肝癌发生、发展及治疗中的作用。肝细胞癌(Hepatocellular Carcinoma, HCC)是一种常见的恶性肿瘤，其发生、发展和转移涉及多种因素。研究表明，血小板在肝癌的肿瘤微环境中发挥关键作用，并在诊断和治疗中具有潜在价值。我们探讨了血小板在肝纤维化、肝癌细胞增殖及转移和肝脏手术后再生中的作用。此外，还讨论了抗血小板疗法在预防肝癌复发方面的有效性及其可能的风险，旨在为肝癌治疗提供全面的治疗策略。
This article comprehensively reviews the role of platelets in the occurrence, development, and treatment of hepatocellular carcinoma (Hepatocellular Carcinoma, HCC). HCC, a common malignant tumor, involves various factors in its development, progression, and metastasis. The study high-lights the critical role of platelets in the tumor microenvironment of liver cancer and their potential value in diagnosis and treatment. It discusses the involvement of platelets in liver fibrosis, prolifer-ation of liver cancer cells, metastasis, and liver regeneration post-surgery. Additionally, the article examines the effectiveness and potential risks of antiplatelet therapy in preventing the recurrence of liver cancer, aiming to provide comprehensive treatment strategies for liver cancer.
| [1] | Callea, F., Favret, M., Marino, C., et al. (1991) Epidemiology of Hepatocellular Carcinoma. |
| [2] | Cancer Today: Data Visualization Tools for Exploring the Global Cancer Burden in 2020.
https://gco.iarc.fr/today/home |
| [3] | Jemal, A., Murray, T., Samuels, A., et al. (2003) Cancer Statistics, 2003. CA: A Cancer Journal for Clinicians, 53, 5-26. https://doi.org/10.3322/canjclin.53.1.5 |
| [4] | Yamashita, T. and Kaneko, S. (2016) [Liver Cancer]. Rinsho Byori. The Japanese Journal of Clinical Pathology, 64, 787-796. |
| [5] | Tachi, Y., Hirai, T., Miyata, A., et al. (2015) Progressive Fibrosis Significantly Correlates with Hepatocellular Carcinoma in Patients with a Sustained Virological Response. Hepatology Research, 45, 238-246.
https://doi.org/10.1111/hepr.12331 |
| [6] | Bataller, R. and Brenner, D.A. (2005) Liver Fibrosis. Journal of Clinical Investigation, 115, 209-218.
https://doi.org/10.1172/JCI24282 |
| [7] | Gressner, A.M. and Weiskirchen, R. (2006) Modern Pathogenetic Concepts of Liver Fibrosis Suggest Stellate Cells and TGF-Beta as Major Players and Therapeutic Targets. Journal of Cellular and Molecular Medicine, 10, 76-99.
https://doi.org/10.1111/j.1582-4934.2006.tb00292.x |
| [8] | Friedman, S.L. (1993) Seminars in Medicine of the Beth Israel Hospital Boston. The Cellular Basis of Hepatic Fibrosis. Mechanisms and Treatment Strategies. The New England Journal of Medicine, 328, 1828-1835.
https://doi.org/10.1056/NEJM199306243282508 |
| [9] | Friedman, S.L., Maher, J.J. and Bissell, D.M. (2000) Mechanisms and Therapy of Hepatic Fibrosis: Report of the AASLD Single Topic Basic Research Conference. Hepa-tology, 32, 1403-1408.
https://doi.org/10.1053/jhep.2000.20243 |
| [10] | Ikeda, N., Murata, S., Maruyama, T., et al. (2012) Platelet-Derived Adenosine 5’-Triphosphate Suppresses Activation of Human Hepatic Stellate Cell: In Vitro Study. Hepatology Research, 42, 91-102.
https://doi.org/10.1111/j.1872-034X.2011.00893.x |
| [11] | Murata, S., Hashimoto, I., Nakano, Y., Myronovych, A., Watanabe, M. and Ohkohchi, N. (2008) Single Administration of Thrombopoietin Prevents Progression of Liver Fibrosis and Promotes Liver Regeneration after Partial Hepatectomy in Cirrhotic Rats. Annals of Surgery, 248, 821-828. https://doi.org/10.1097/SLA.0b013e31818584c7 |
| [12] | Watanabe, M., Murata, S., Hashimoto, I., et al. (2009) Plate-lets Contribute to the Reduction of Liver Fibrosis in Mice. Journal of Gastroenterology and Hepatology, 24, 78-89. https://doi.org/10.1111/j.1440-1746.2008.05497.x |
| [13] | Aryal, B., Yamakuchi, M., Shimizu, T., et al. (2018) Deci-phering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology, 2018, Article ID: 9142672. https://doi.org/10.1155/2018/9142672 |
| [14] | Huang, P., Xu, X., Wang, L., et al. (2014) The Role of EGF-EGFR Signalling Pathway in Hepatocellular Carcinoma Inflamma-tory Microenvironment. Journal of Cellular and Molecular Medicine, 18, 218-230.
https://doi.org/10.1111/jcmm.12153 |
| [15] | D’Alessandro, R., Refolo, M.G., Lippolis, C., et al. (2014) Antagonism of Sorafenib and Regorafenib Actions by Platelet Factors in Hepatocellular Carcinoma Cell Lines. BMC Cancer, 14, Ar-ticle No. 351.
https://doi.org/10.1186/1471-2407-14-351 |
| [16] | Badawy, A.A., El-Hindawi, A., Hammam, O., et al. (2015) Impact of Epidermal Growth Factor Receptor and Transforming Growth Factor-α on Hepatitis C Virus-Induced Hepatocarcino-genesis. APMIS, 123, 823-831.
https://doi.org/10.1111/apm.12431 |
| [17] | Fuchs, B.C., Hoshida, Y., Fujii, T., et al. (2014) Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma. Hepatology, 59, 1577-1590. https://doi.org/10.1002/hep.26898 |
| [18] | Chen, B., Liu, J., Wang, X., et al. (2018) Co-Expression of PDGF-B and VEGFR-3 Strongly Correlates with Poor Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy. Clinics and Research in Hepatology and Gastroenterology, 42, 126-133. https://doi.org/10.1016/j.clinre.2016.11.006 |
| [19] | Zhan, P., Qian, Q. and Yu, L.K. (2013) Serum VEGF Level Is Associated with the Outcome of Patients with Hepatocellular Carcinoma: A Meta-Analysis. Hepatobiliary Surgery and Nutrition, 2, 209-215. |
| [20] | Takagi, S., Sato, S., Oh-Hara, T., et al. (2013) Platelets Promote Tumor Growth and Metas-tasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2. PLOS ONE, 8, E73609. https://doi.org/10.1371/journal.pone.0073609 |
| [21] | Leslie, M. (2010) Cell Biology: Beyond Clotting: The Powers of Platelets. Science, 328, 562-564.
https://doi.org/10.1126/science.328.5978.562 |
| [22] | Bihari, C., Rastogi, A., Shasthry, S.M., et al. (2016) Platelets Contribute to Growth and Metastasis in Hepatocellular Carcinoma. APMIS, 124, 776-786. https://doi.org/10.1111/apm.12574 |
| [23] | Morimoto, Y., Nouso, K., Wada, N., et al. (2014) Involvement of Platelets in Extrahepatic Metastasis of Hepatocellular Carcinoma. Hepatology Research, 44, E353-E359. https://doi.org/10.1111/hepr.12315 |
| [24] | Lee, C.-H., Lin, Y.-J., Lin, C.-C., et al. (2015) Pretreatment Platelet Count Early Predicts Extrahepatic Metastasis of Human Hepatoma. Liver International, 35, 2327-2336. https://doi.org/10.1111/liv.12817 |
| [25] | Gasic, G.J., Gasic, T.B. and Stewart, C.C. (1968) Antimetastatic Effects Associated with Platelet Reduction. Proceedings of the National Academy of Sciences of the United States of America, 61, 46-52.
https://doi.org/10.1073/pnas.61.1.46 |
| [26] | Nakamura, T., Nawa, K. and Ichihara, A. (1984) Partial Purification and Characterization of Hepatocyte Growth Factor from Serum of Hepatectomized Rats. Biochemical and Biophysical Re-search Communications, 122, 1450-1459.
https://doi.org/10.1016/0006-291X(84)91253-1 |
| [27] | Nakamura, T. (1987) Platelet-Derived Growth Regulators and Mechanism of Liver Regeneration. Tanpakushitsu Kakusan Koso, 32, 1113-1125. |
| [28] | Matsuo, R., Nakano, Y., Ohkohchi, N. (2011) Platelet Administration via the Portal Vein Promotes Liver Regeneration in Rats after 70% Hepa-tectomy. Annals of Surgery, 253, 759-763. https://doi.org/10.1097/SLA.0b013e318211caf8 |
| [29] | Myronovych, A., Murata, S., Chiba, M., et al. (2010) Role of Platelets on Liver Regeneration after 90% Hepatectomy in Mice. Journal of Hepatology, 49, 363-372. https://doi.org/10.1016/j.jhep.2008.04.019 |
| [30] | Lopez, M., Kieling, C., Uribe Cruz, C., et al. (2013) Platelet Increases Survival in A Model of 90% Hepatectomy in Rats. Liver International, 34, 1049-1056. https://doi.org/10.1111/liv.12326 |
| [31] | Padickakudy, R., Pereyra, D., Offensperger, F., et al. (2017) Bivalent Role of Intra-Platelet Serotonin in Liver Regeneration and Tumor Recurrence in Humans. Journal of Hepatology, 67, 1243-1252.
https://doi.org/10.1016/j.jhep.2017.08.009 |
| [32] | Lesurtel, M., Raptis, D.A., Melloul, E., et al. (2014) Low Platelet Counts after Liver Transplantation Predict Early Posttransplant Survival: The 60-5 Criterion. Liver Transplantation, 20, 147-155. https://doi.org/10.1002/lt.23759 |
| [33] | Alkozai, E.M., Nijsten, M.W., De, Jong, K.P., et al. (2010) Imme-diate Postoperative Low Platelet Count Is Associated with Delayed Liver Function Recovery after Partial Liver Resection. Annals of Surgery, 251, 300-306.
https://doi.org/10.1097/SLA.0b013e3181b76557 |
| [34] | Lai, Q., Castro Santa, E., Rico Juri, J.M., et al. (2014) Neu-trophil and Platelet-to-Lymphocyte Ratio as New Predictors of Dropout and Recurrence after Liver Transplantation for Hepatocellular Cancer. Transplant International, 27, 32-41.
https://doi.org/10.1111/tri.12191 |
| [35] | Xia, W., Ke, Q., Guo, H., et al. (2017) Expansion of the Milan Criteria without Any Sacrifice: Combination of the Hangzhou Criteria with the Pre-Transplant Platelet-to-Lymphocyte Ratio. BMC Cancer, 17, Article No. 14.
https://doi.org/10.1186/s12885-016-3028-0 |
| [36] | Sahasrabuddhe, V.V., Gunja, M.Z., Graubard, B.I., et al. (2012) Nonsteroidal Anti-Inflammatory Drug Use, Chronic Liver Disease and Hepatocellular Carcinoma. JNCI: Journal of the National Cancer Institute, 104, 1808-1814.
https://doi.org/10.1093/jnci/djs452 |
| [37] | Vlachogiannakos, J., et al. (2013) Hepatocellular Carcinoma in Chronic Hepatitis B Patients under Antiviral Therapy. World Journal of Gastroenterology, 19, 8822-8830. https://doi.org/10.3748/wjg.v19.i47.8822 |
| [38] | Lee, P.C., Yeh, C.M., Hu, Y.W., et al. (2016) Antiplatelet Therapy Is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Annals of Surgical Oncology, 23, 874-883. https://doi.org/10.1245/s10434-016-5520-9 |
| [39] | Li, J.H., Wang, Y., Xie, X.Y., et al. (2016) Aspirin in Combination with TACE in Treatment of Unresectable HCC: A Matched-Pairs Analysis. American Journal of Cancer Research, 6, 2109-2116. |
| [40] | Boas, F.E., Brown, K.T., Ziv, E., et al. (2019) Aspirin Is Associated with Improved Liver Function after Embolization of Hepatocellular Carcinoma. AJR American Journal of Roentgenology, 213, 1-7.
https://doi.org/10.2214/AJR.18.20846 |
| [41] | Tao, Y.Q. (2018) Nonsteroidal Anti-Inflammatory Drugs Especially Aspirin Are Linked to Lower Risk and Better Survival of Hepatocellular Carcinoma: A Meta-Analysis. Cancer Man-agement & Research, 10, 2695-2709.
https://doi.org/10.2147/CMAR.S167560 |
| [42] | Li, X., Yu, Y. and Liu, L. (2021) Influence of Aspirin Use on Clini-cal Outcomes of Patients with Hepatocellular Carcinoma: A Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101545.
https://doi.org/10.1016/j.clinre.2020.09.006 |
